Price target

50.26DEUR+8.44+20.19%
The 14 analysts offering 1 year price forecasts for CHUGAI PHARMACEUT'L have a max estimate of 72.34 and a min estimate of 38.04.

Analyst rating

Based on 17 analysts giving stock ratings to CHUGAI PHARMACEUT'L in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
7
Buy
2
Hold
7
Sell
1
Strong sell
0

EPS

Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
‪0.00‬
‪0.12‬
‪0.24‬
‪0.36‬
‪0.48‬
Reported
Estimate
Currency: EUR
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
‪0.32‬
‪0.30‬
‪0.36‬
‪0.28‬
‪0.39‬
‪0.42‬
‪0.34‬
Estimate
‪0.26‬
‪0.31‬
‪0.33‬
‪0.29‬
‪0.31‬
‪0.38‬
‪0.36‬
‪0.30‬
‪0.44‬
‪0.43‬
‪0.46‬
Surprise
+21.97%
−3.58%
+9.18%
−4.31%
+25.76%
+10.19%
−5.67%

Revenue

Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
‪0.00‬
‪‪600.00 M‬‬
‪‪1.20 B‬‬
‪‪1.80 B‬‬
‪‪2.40 B‬‬
Reported
Estimate
Currency: EUR
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
‪‪1.70 B‬‬
‪‪1.63 B‬‬
‪‪1.76 B‬‬
‪‪1.45 B‬‬
‪‪1.83 B‬‬
‪‪1.97 B‬‬
‪‪1.86 B‬‬
Estimate
‪‪1.45 B‬‬
‪‪1.48 B‬‬
‪‪1.83 B‬‬
‪‪1.49 B‬‬
‪‪1.60 B‬‬
‪‪1.85 B‬‬
‪‪1.79 B‬‬
‪‪1.60 B‬‬
‪‪2.04 B‬‬
‪‪2.02 B‬‬
‪‪1.82 B‬‬
Surprise
+17.11%
+10.01%
−4.05%
−2.38%
+14.65%
+6.51%
+3.61%
Be warned

Frequently Asked Questions


CUP EPS for the last quarter is 0.34 EUR despite the estimation of 0.36 EUR. In the next quarter EPS is expected to reach 0.30 EUR. Track more of CHUGAI PHARMACEUT'L financials and stay on top of what is up with the company.
In the next quarter CHUGAI PHARMACEUT'L revenue is expected to reach ‪1.61 B‬ EUR. Check out CHUGAI PHARMACEUT'L revenue and earnings and make informed decisions.
According to analysts, CUP price target is 50.26 EUR with a max estimate of 72.33 EUR and a min estimate of 38.04 EUR. Check if this forecast comes true in a year, meanwhile watch CHUGAI PHARMACEUT'L stock price chart and keep track of the current situation with CUP news and stock market news.
We've gathered opinions of 17 analysts rating CUP stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.